Question

Difficulty: MediumPediatric Cardiovascular Disorders

A 2-year-old boy is brought to the pediatric emergency department with a 6-day history of high fever, bilateral non-exudative conjunctivitis, cracked red lips, and a polymorphous maculopapular rash on his trunk. Physical examination reveals cervical lymphadenopathy and erythema of the palms and soles. A clinical diagnosis of Kawasaki disease is made. Arrange the following steps in the correct chronological sequence for the standard management and follow-up of this patient.

  1. 1Administer a single infusion of intravenous immunoglobulin (IVIG) and high-dose aspirin.
  2. 2Transition to low-dose aspirin therapy once the patient is afebrile for 48 hours.
  3. 3Perform a follow-up echocardiogram 2 to 6 weeks after the onset of illness.
  4. 4Administer scheduled live-attenuated vaccines (e.g., measles-mumps-rubella).

Answer

The correct chronological sequence is: 1) Administer IVIG and high-dose aspirin; 2) Transition to low-dose aspirin therapy; 3) Perform a follow-up echocardiogram; 4) Administer scheduled live-attenuated vaccines.
The standard sequence for Kawasaki disease management follows the clinical phases of the illness. In the acute phase, immediate administration of IVIG and high-dose aspirin is paramount to prevent coronary artery aneurysms. In the subacute phase (once the patient is afebrile for 48 hours), the aspirin dose is decreased to an antiplatelet level. In the convalescent phase (2 to 6 weeks), a follow-up echocardiogram is obtained to check for delayed coronary artery changes. Finally, 11 months after IVIG administration, live-attenuated vaccines can safely be administered without interference from the passive antibodies in IVIG.

Step-by-Step Solution

1
Identify the acute phase treatment.
Administer intravenous immunoglobulin (IVIG) and high-dose aspirin.
Immediate treatment within the first 10 days is required to halt systemic inflammation and prevent the formation of coronary artery aneurysms.
2
Determine the step for the subacute phase.
Transition to low-dose aspirin.
After the patient is afebrile for 48 hours, anti-inflammatory doses are no longer needed, but antiplatelet doses are required to mitigate the risk of thrombosis from reactive thrombocytosis.
3
Identify the convalescent monitoring requirement.
Perform a follow-up echocardiogram at 2 to 6 weeks.
Coronary artery changes typically evolve over weeks; a follow-up scan is essential to ensure no delayed aneurysms have formed since the baseline imaging.
4
Determine long-term pediatric care adjustments.
Administer scheduled live-attenuated vaccines.
Because IVIG contains pooled IgG that neutralizes live viruses, live-attenuated vaccines must be deferred for 11 months to ensure they generate an effective immune response.

Key Concept

Management timeline for Kawasaki disease requires acute IVIG/high-dose aspirin, subacute aspirin de-escalation, convalescent echocardiography, and long-term vaccine deferral.
Estimated Time:1m 0s
Rate this question